CCND2 and non-small cell lung carcinoma: JPX is a major oncogene that is elevated in NSCLC tissues and is linked to a poor prognosis [24]; JPX interacts with miR-145-5p to increase cyclin D2 expression in a ceRNA pathway, promoting the growth and development of NSCLC [25].